What 4 Analyst Ratings Have To Say About Intuitive Surgical
Within the last quarter, Intuitive Surgical (NASDAQ:ISRG) has observed the following analyst ratings:
BTIG Upgrades Intuitive Surgical to Buy, Announces $372 Price Target
BTIG analyst Ryan Zimmerman upgrades Intuitive Surgical (NASDAQ:ISRG) from Neutral to Buy and announces $372 price target.
Morgan Stanley Maintains Equal-Weight on Intuitive Surgical, Raises Price Target to $325
Morgan Stanley analyst Drew Ranieri maintains Intuitive Surgical (NASDAQ:ISRG) with a Equal-Weight and raises the price target from $310 to $325.
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
Just before Tuesday’s close, Netflix (NASDAQ: NFLX) reported better-than-expected earnings by adding 4.4 million subscribers in the third quarter.
Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $381
Wells Fargo analyst Larry Biegelsen maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and raises the price target from $354 to $381.
Intuitive’s Q3 Earnings Slightly Edges Out Expectations
Intuitive Surgical Inc (NASDAQ:ISRG) reported Q3 adjusted EPS of $1.19, slightly ahead of the consensus of $1.17. It reported revenues…
Intuitive Surgical Q3 EPS $1.19 Beats $1.17 Estimate, Sales $1.40B Beat $1.39B Estimate
Intuitive Surgical (NASDAQ:ISRG) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.17 by 1.71 percent. This is a 29.35 percent increase over earnings of $0.92 per share from